Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug interactions with phenytoin

E Perucca, A Richens

    Drugs
    |February 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Phenytoin drug interactions can significantly alter its effectiveness and serum levels, particularly when its metabolism is inhibited or when it induces the metabolism of other drugs. Careful monitoring is essential for safe and effective phenytoin therapy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Impact of generic substitution of anticonvulsants on the treatment of epilepsy.

    CNS drugs·2013
    Same author

    Inhibition of phenytoin metabolism by sulthiame in epileptic patients.

    British journal of clinical pharmacology·2012
    Same author

    Effect of diazepam on oculomotor balance.

    British journal of clinical pharmacology·2012
    Same author

    Rate of elimination of tracer doses of phenytoin at different steady-state serum phenytoin concentrations in epileptic patients.

    British journal of clinical pharmacology·2012
    Same author

    The influence of elevated plasma hydrocortisone concentrations on antipyrine metabolism in man.

    British journal of clinical pharmacology·2012
    Same author

    α-adrenoceptor blocking drugs, pressor responses to noradrenaline, and the ankle jerk in man.

    British journal of clinical pharmacology·2012
    Same journal

    The Long Road to Long-Acting: What Oral PrEP and CAB-LA Teach Us About Scaling Lenacapavir.

    Drugs·2026
    Same journal

    Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews.

    Drugs·2026
    Same journal

    Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug Reactions.

    Drugs·2026
    Same journal

    Use of Sedative-Hypnotic Drugs and the Risk of Developing Alzheimer's Disease: A Systematic Review, Meta-Analysis and Meta-Regression.

    Drugs·2026
    Same journal

    Relacorilant: First Approval.

    Drugs·2026
    Same journal

    Developmental Progress and Future Potential for Inhaled Biologics in the Treatment of Respiratory Diseases.

    Drugs·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Clinical Pharmacy
    • Drug Metabolism

    Background:

    • Drug interactions involving phenytoin are common, with varying clinical significance.
    • Phenytoin's metabolism is saturable, making it sensitive to interactions that inhibit this process.
    • Phenytoin is a potent enzyme inducer, affecting the efficacy of numerous co-administered medications.

    Purpose of the Study:

    • To review the clinical relevance of drug interactions with phenytoin.
    • To highlight interactions affecting phenytoin metabolism and its enzyme-inducing properties.
    • To discuss the impact of protein binding interactions on phenytoin's therapeutic effect.

    Main Methods:

    • Literature review of documented phenytoin drug interactions.
    • Analysis of pharmacokinetic and pharmacodynamic consequences of these interactions.

    Related Experiment Videos

  • Clinical case examples illustrating significant interactions.

    • Main Results:

    • Inhibition of phenytoin metabolism can lead to disproportionate increases in serum concentrations and pharmacological effects.
    • Phenytoin's enzyme-inducing properties can reduce the efficacy of drugs like dicoumarol, oral contraceptives, and corticosteroids.
    • Plasma protein binding interactions are generally less significant unless other mechanisms are involved.

    Conclusions:

    • Drug interactions significantly impact phenytoin therapy, necessitating careful consideration of co-administered drugs.
    • Understanding phenytoin's metabolic pathways and enzyme-inducing potential is crucial for managing interactions.
    • Interpreting serum phenytoin levels requires awareness of potential alterations due to drug interactions and protein binding.